Wolters Kluwer, which provides professional information, software solutions and services for clinicians, nurses, accountants, lawyers and the tax, finance, audit, risk, compliance and regulation, is seeing greater adoption of its solutions and services in India. specifically by healthcare professionals, a senior executive said.
“The adoption of clinical decision support technology in India has been impressive and dynamic. In less than a decade, we have seen substantial growth in the number of users,” Christian Cella, vice president of international clinical effectiveness markets at Wolters Kluwer, said in an email interview.
“We have over 10 million hits on our platform in India in the last 12 months. This usage indicates that Indian clinicians are finding value in this technology. Adoption may vary depending on the type of institution, but overall the response has been positive and encouraging,” he said.
Stating that major institutions such as the All India Institute of Medical Sciences and eminent private hospitals have been using our solution for over a decade, he said the company has witnessed strong adoption by both government and private institutions , with more than 270 hospitals using its technology.
“Usage is high and growing in small hospitals, individual practices and even primary care settings. The user base includes not only physicians, but also nurses, clinical pharmacists, and other healthcare professionals who benefit from evidence-based decision support. » said Mr. Cella.
He said adoption of the company’s solutions has grown across tier one, tier two and even smaller healthcare settings, especially with increased internet penetration across the country.
“We are focused on expanding our reach and are already experiencing rapid growth. Although there are challenges, initiatives such as India’s shift towards digital technology in healthcare are positive indicators for us. We aim to work more closely with administrations, both at the central and state levels,” he said.
He said that as the role of clinicians continues to evolve, the company sees the need for them to have access to integrated, user-empowering technology that supports rapidly evolving workflows .
“Our solutions require very minimal infrastructure changes and address the critical need for accessible, standardized and valuable patient care. In India, we are seeing significant growth and adoption,” he said.
Cella said that using the company’s tools, clinicians can access structured summaries and treatment recommendations for various diseases. With content curated by a group of more than 8,000 subject matter experts worldwide, each topic undergoes rigorous peer review to ensure high accuracy and relevance.
“This process ensures that the information provided is reliable and consistent, which is essential for clinicians to make informed decisions. Our recommendations are based on the latest evidence-based guidelines and our goal is to provide the most authoritative and reliable clinical information,” he said.
He said the technology his company developed has driven significant transformation as it addresses one of the biggest concerns in the healthcare industry today: medical burnout.
“It also addresses the issue of variability of care and significantly improves patient safety.” Without clinical decision support, treatment approaches can differ significantly based on physician knowledge and updated information,” he said.
“By standardizing and streamlining treatment recommendations, our technology reduces this variability, benefiting both patients and the healthcare system.” One of the major transformations is that doctors are willingly adopting this technology. Doctors are under enormous stress and appreciate tools that help them make decisions,” he added.
This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every month
You have exhausted your limit of free items. Please support quality journalism.
You have exhausted your limit of free items. Please support quality journalism.
You read {{data.cm.views}} out of {{data.cm.maxViews}} free items.
This is your last free article.